Table 1.
Respondents (n=1159) | Nonrespondents (n=265) | Patients with unverifiable addresses (n=118) | P value | |
---|---|---|---|---|
Mean age at time of survey (SD) | 69.2 (9.7) | 71.1 (10.2) | 68.3 (11.4) | 0.008 |
Mean years since diagnosis (SD) | 3.5 (1.5) | 3.6 (1.6) | 3.7 (1.5) | 0.530 |
Gender | 0.003 | |||
Male | 663 (57.2%) | 121 (45.7%) | 63 (53.4%) | |
Female | 496 (42.8%) | 144 (54.3%) | 55 (46.6%) | |
Stage at diagnosisa | 0.507 | |||
I | 309 (26.7%) | 71 (26.8%) | 33 (28.0%) | |
II | 450 (38.8%) | 108 (40.8%) | 47 (39.8%) | |
III | 331 (28.6%) | 78 (29.4%) | 29 (24.6%) | |
IV | 69 (6.0%) | 8 (3.0%) | 9 (7.6%) | |
Primary treatment | 0.253 | |||
SU only | 599 (51.7%) | 162 (61.6%) | 64 (54.2%) | |
SU+RT | 231 (19.9%) | 38 (14.4%) | 21 (17.8%) | |
SU+CT | 250 (21.6%) | 48 (18.3%) | 23 (19.5%) | |
SU+RT+CT | 68 (5.9%) | 12 (4.6%) | 9 (7.6%) | |
CT only | 11 (0.9%) | 3 (1.1%) | 1 (0.8%) |
Disease stage at primary diagnosis.
CT, chemotherapy; SD, standard deviation; SU, surgery; RT, radiotherapy.